Search results for "virus infection"

showing 10 items of 797 documents

Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination.

2011

Cytomegalovirus (CMV) is frequently transmitted by solid organ transplantation and is associated with graft failure. By forming the boundary between circulation and organ parenchyma, endothelial cells (EC) are suited for bidirectional virus spread from and to the transplant. We applied Cre/loxP-mediated green-fluorescence-tagging of EC-derived murine CMV (MCMV) to quantify the role of infected EC in transplantation-associated CMV dissemination in the mouse model. Both EC- and non-EC-derived virus originating from infected Tie2-cre + heart and kidney transplants were readily transmitted to MCMV-naïve recipients by primary viremia. In contrast, when a Tie2-cre + transplant was infected by pri…

Human cytomegalovirusMuromegalovirusmedicine.medical_treatmentKidneyMicelcsh:QH301-705.5Kidney transplantationHeart transplantationbiologyvirus diseasesHeartAnimal ModelsHost-Pathogen InteractionInfectious Diseasessurgical procedures operativemedicine.anatomical_structureOncologyMedical MicrobiologyCytomegalovirus InfectionsMedicineResearch Articlelcsh:Immunologic diseases. AllergyEndotheliumImmunologyCongenital cytomegalovirus infection610ViremiaMice TransgenicMicrobiologyVirusModel OrganismsMuromegalovirusVirologyGeneticsmedicineAnimalsViremiaBiologyMolecular BiologyEndothelial Cellsmedicine.diseasebiology.organism_classificationVirologyKidney Transplantationlcsh:Biology (General)ImmunologyHeart TransplantationSurgeryParasitologyEndothelium Vascularlcsh:RC581-607PLoS pathogens
researchProduct

The immunogenicity of human and murine cytomegaloviruses.

2000

Cytomegaloviruses are strictly host-species-specific. During an aeon of co-evolution, virus and host have found an arrangement: the productive and cytopathogenic cycle of viral gene expression is held in check by the host's immune response. As a consequence, cytomegalovirus disease is restricted to the immunocompromised host. The virus has evolved strategies to avoid its elimination and eventually hides itself in a silent state, referred to as 'viral latency'. Redundant molecular mechanisms have been identified by which cytomegaloviruses interfere with antigen presentation pathways to 'evade' immune control. In the annual period covered by this review, the IE1 protein was revisited as an im…

Human cytomegalovirusMuromegalovirusvirusesImmunologyAntigen presentationCongenital cytomegalovirus infectionCytomegalovirusImmunodominanceBiologyVirusImmediate early proteinImmediate-Early ProteinsViral Matrix ProteinsMiceViral ProteinsAntigenmedicineImmunology and AllergyAnimalsHumansAntigen PresentationImmunogenicityHistocompatibility Antigens Class IIvirus diseasesReceptors Antigen T-Cell gamma-deltamedicine.diseasePhosphoproteinsVirologyKiller Cells NaturalImmunologyCurrent opinion in immunology
researchProduct

Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining

1993

Chronic villitis is almost always present in intrauterine infection with human cytomegalovirus (HCMV). The inflammatory response to this virus has been described in detail. However, little is known about the types of placental cells that may be infected by HCMV and six cases of HCMV placentitis were thus investigated to identify the vulnerable cell types. Immunohistochemical double staining analyses were performed using antibodies to HCMV immediate early antigens and to specific cellular marker proteins. Fixed connective tissue cells could be demonstrated to be the predominantly infected cell type in each placental tissue. Endothelial cells and macrophages were also found to be infected in …

Human cytomegalovirusPathologymedicine.medical_specialtyPlacenta DiseasesTransplacental transmissionvirusesCongenital cytomegalovirus infectionCytomegalovirusConnective tissuePathology and Forensic MedicineAntigenPregnancymedicineHumansVimentinMacrophageEndotheliumPregnancy Complications InfectiousAntigens ViralMolecular BiologyCytopathic effectbiologyMacrophagesvirus diseasesCell BiologyGeneral Medicinemedicine.diseaseImmunohistochemistryVirologymedicine.anatomical_structureConnective TissueCytomegalovirus Infectionsbiology.proteinFemaleAntibodyVirchows Archiv A Pathological Anatomy and Histopathology
researchProduct

Protein delivery by subviral particles of human cytomegalovirus

2003

Direct protein delivery is an emerging technology in vaccine development and gene therapy. We could previously show that subviral dense bodies (DB) of human cytomegalovirus (HCMV), a beta-herpesvirus, transport viral proteins into target cells by membrane fusion. Thus these non-infectious particles provide a candidate delivery system for the prophylactic and therapeutic application of proteins. Here we provide proof of principle that DB can be modified genetically. A 55 kDa fusion protein consisting of the green fluorescent protein and the neomycin phosphotransferase could be packed in and delivered into cells by recombinant DB in a functional fashion. Furthermore, transfer of protein into …

Human cytomegalovirusRecombinant Fusion ProteinsGenetic enhancementGenetic VectorsGreen Fluorescent ProteinsCongenital cytomegalovirus infectionCytomegalovirusGene ExpressionBiologylaw.inventionGreen fluorescent proteinlawVaccines DNAGeneticsmedicineHumansMolecular BiologyKanamycin KinaseSecretory VesiclesLipid bilayer fusionDendritic CellsGenetic TherapyFibroblastsmedicine.diseaseFusion proteinVirologyCell biologyLuminescent ProteinsFluorescent Antibody Technique DirectRecombinant DNAMolecular MedicineDelivery systemGenetic EngineeringGene Therapy
researchProduct

Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations

2003

Human cytomegalovirus (HCMV) strains, obtained from immunocompetent and immunocompromised Italian hosts, were typed with glycoprotein B (gB) gene restriction analysis. A predominant circulation of HCMV strains with gB type 2 and 3 was detected in both the immunocompetent host with a primary HCMV infection and the immunocompromised host with or without HCMV disease. No association between gB types and subjects with different risks of developing HCMV disease was found. All four gB genotypes were capable of causing congenital infection in Italian babies, with gB type 1 accounting for 50% of the strains examined in symptomatic infants and a remarkable incidence of gB type 4 viruses.

Human cytomegalovirusSettore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialtyGenotypevirusesRestriction MappingCongenital cytomegalovirus infectionCytomegalovirusHIV Infectionsmedicine.disease_causePolymerase Chain ReactionHerpesviridaeVirusImmunocompromised HostMedical microbiologyViral Envelope ProteinsBetaherpesvirinaeVirologyGenotypemedicineHumansBone Marrow TransplantationbiologyInfant Newbornvirus diseasesGeneral Medicinebiology.organism_classificationmedicine.diseaseKidney TransplantationVirologyHuman cytomegalovirus immunocompromised gB genotypes ItalyCytomegalovirus InfectionsViral diseaseImmunocompetenceArchives of Virology
researchProduct

An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurr…

2001

Primary human cytomegalovirus (HCMV) infection during pregnancy is a frequent cause of fatal damage in populations with low prevalence of HCMV. Differentiation of primary vs. recurrent HCMV infection is an important issue in prenatal counseling. Antibodies specific for viral glycoproteins become detectable only with considerable delay with relation to HCMV infection or IgG seroconversion. Thus, lack of glycoprotein specific (gp-specific) antibodies can serve as a convenient indicator to identify those pregnant women that bear an elevated risk for HCMV transplacental transmission and fetal sequelae. In the opposite case, presence of gp-specific antibodies virtually excludes HCMV primary infe…

Human cytomegalovirusTransplacental transmissionvirusesCytomegalovirusEnzyme-Linked Immunosorbent AssayBiologyAntibodies ViralVirusNeutralizationDiagnosis DifferentialViral Envelope ProteinsAntigenNeutralization TestsRecurrenceVirologymedicineHumansSeroconversionAntigens Viralbiochemical phenomena metabolism and nutritionmedicine.diseaseVirologyTiterInfectious DiseasesAcute DiseaseCytomegalovirus InfectionsImmunologybiology.proteinAntibodyJournal of Medical Virology
researchProduct

Suppression of CD8+ T cell recognition in the immediate-early phase of human cytomegalovirus infection.

2012

Human cytomegalovirus (HCMV) interferes with MHC class I-restricted antigen presentation and thereby reduces recognition by CD8+ T-cells. This interference is mediated primarily by endoplasmic reticulum-resident glycoproteins that are encoded in the US2–11 region of the viral genome. Such a suppression of recognition would be of particular importance immediately after infection, because several immunodominant viral antigens are already present in the cell in this phase. However, which of the evasion proteins gpUS2–11 interfere(s) with antigen presentation to CD8+ T-cells at this time of infection is not known. Here we address this question, using recombinant viruses (RV) that express only o…

Human cytomegalovirusVirulence FactorsvirusesAntigen presentationCytomegalovirusCD8-Positive T-LymphocytesCell LineImmune toleranceViral ProteinsViral Envelope ProteinsAntigenVirologyMHC class IImmune TolerancemedicineHumansCytotoxic T cellImmune EvasionbiologyHistocompatibility Antigens Class IRNA-Binding Proteinsvirus diseasesmedicine.diseaseVirologyCell cultureCytomegalovirus InfectionsImmunologybiology.proteinCD8
researchProduct

Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytom…

2001

Serum neutralizing and glycoprotein B (gB)-specific antibody levels were monitored prospectively in AIDS patients who either did or did not develop human cytomegalovirus (HCMV) end-organ disease, to delineate further the role of antibodies in protecting against HCMV disease. Antibody levels declined substantially (at least 4-fold) only in patients who developed HCMV disease; this decline in turn occurred concurrently with antigenemia. Nevertheless, AIDS patients who remained free of HCMV disease and did not become antigenemic during the follow-up period maintained stable levels of serum antibodies, with only minor fluctuations. The impact of HAART on the levels of functional anti-HCMV antib…

Human cytomegalovirusbiologybusiness.industryvirusesAntibody titerCongenital cytomegalovirus infectionvirus diseasesmedicine.disease_causemedicine.diseasebiology.organism_classificationVirologyHerpesviridaeInfectious DiseasesBetaherpesvirinaeVirologyImmunopathologyImmunologymedicinebiology.proteinViral diseaseAntibodybusinessJournal of Medical Virology
researchProduct

Enzyme Affinity Assays Involving a Single-Use Electrochemical Sensor. Applications to the Enzyme Immunoassay of Human Chorionic Gonadotropin Hormone …

2000

Human cytomegaloviruschemistry.chemical_classificationmedicine.diagnostic_testChemistryCongenital cytomegalovirus infectionmedicine.diseaseMolecular biologyAnalytical ChemistryElectrochemical gas sensorHuman chorionic gonadotropinNucleic acid thermodynamicschemistry.chemical_compoundEnzymeBiochemistryImmunoassayElectrochemistrymedicineDNAElectroanalysis
researchProduct

Identification of a Conserved HLA-A2-Restricted Decapeptide from the IE1 Protein (pUL123) of Human Cytomegalovirus

2002

Abstract Control of human cytomegalovirus (HCMV) infection is predominantly mediated by cytolytic CD8 + T lymphocytes (CTL). Among the roughly 200 HCMV-encoded polypeptides, the tegument protein pp65 (ppUL83) and the nonstructural IE1 protein are considered to be dominant CTL targets. Yet the importance of CTL against IE1 for protective immunity against HCMV reactivation and disease has remained elusive. Analyses have been difficult, as all MHC class I presented peptides of IE1 defined so far are located in parts of the protein that are variable between viral strains. In this study a conserved decameric peptide from IE1 (P6, IE1 354–363 ) that bound to HLA-A2 was identified. Using peptide-p…

Human cytomegalovirusherpesvirusesViral proteinvirusesMolecular Sequence DataIE1CytomegalovirusEpitopes T-Lymphocytecytotoxic T lymphocytesmedicine.disease_causeImmediate early proteinCell LineImmediate-Early ProteinsViral Proteinsconserved CTL epitopesVirologyHLA-A2 AntigenMHC class ImedicineHumansCytotoxic T cellAmino Acid SequenceConserved SequencebiologyELISPOTvirus diseasesHLA-A2biochemical phenomena metabolism and nutritionCytotoxicity Tests Immunologicmedicine.diseaseVirologyPeptide FragmentsVirus LatencyCTL*human cytomegalovirusCytomegalovirus InfectionsImmunologybiology.proteinPeptidesCD8T-Lymphocytes CytotoxicVirology
researchProduct